FDA Allows Juno To Resume Anticancer Treatment Study Juno Therapeutics' cancer study has now been allowed to resume a week after its clinical trials were suspended by the FDA. The trials will continue without a certain chemotherapy drug. by Alyssa Navarro
Health Top 10 Leading Causes Of Death In The US: What Is The No. 1 Killer In America? by Katherine Derla
Health Future Beyond Cancer: What Makes Biden's Cancer Moonshot A Massive Breakthrough? by Katrina Pascual
Health Unexpected Findings Reveal How Cancer Spreads, Insights Could Lead To New Tumor-Blocking Treatments by Katherine Derla
Health Patient Position During Breast MRI May Influence Success Of Tumor Removal During Lumpectomy by Rhodi Lee
Health Federal Panel Approves First Human Clinical Trial For Controversial Gene-Editing Tool CRISPR by Katherine Derla
Health Can Drinking Coffee Cause Cancer? WHO Says Only If Beverage Is Drunk At Very Hot Temperature by Rhodi Lee
Health Blood-Based Liquid Biopsy Offers Reliable Alternative To Conventional Tests To Diagnose Cancer: Study by Rhodi Lee
Health New Pancreatic Cancer Therapy Increases Survival Rates Of Patients by Catherine Cabral-Isabedra
Health Young Female Cancer Survivors Need More Information On Fertility Preservation by Alyssa Navarro
Health Jimmy Carter's Immune Drug Keytruda Helps Cancer Patients Live Three Years Longer by Katrina Pascual
Health 7-Year-Old Boy Who Donated Hair To Child Cancer Patients Diagnosed With Metastatic Cancer by Katherine Derla
Health Cancer Drug Prices Up By 600 Percent: What Drives Increase In Medication Costs? by Rina Marie Doctor
Health Women's Survival Rate For 13 Cancers Is Higher Than Men: Statistics Canada by Catherine Cabral-Isabedra